Bicocca Open Archive

Logo unimib boa

Callari, M., Huang, C., Egle, D., Bermejo, B., Zamagni, C., Dugo, M., et al. (2022). Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial. In Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10. American Association for Cancer Research [10.1158/1538-7445.SABCS21-P1-04-02].

Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial

Barreca, M;
2022
abstract + poster
Breast Cancer; Trascriptomics
English
2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10
2021
Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10
CANCER RESEARCH
2022
82
4S
P1-04-02
https://aacrjournals.org/cancerres/article/82/4_Supplement/P1-04-02/680410/Abstract-P1-04-02-Immune-milieu-associated-with-PD
none
Callari, M., Huang, C., Egle, D., Bermejo, B., Zamagni, C., Dugo, M., et al. (2022). Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial. In Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10. American Association for Cancer Research [10.1158/1538-7445.SABCS21-P1-04-02].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/453702
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact